MACKŮ, Jan, Kateřina KUBOVÁ, Martina URBANOVA, Jan MUSELÍK, Aleš FRANC, Gabriela KOUTNÁ, Miroslava PAVELKOVÁ, David VETCHÝ, Josef MASEK, Eliska MASKOVA and Jiri BRUS. Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing. Pharmaceutics. Basel: MDPI, 2022, vol. 14, No 8, p. 1-21. ISSN 1999-4923. Available from: https://dx.doi.org/10.3390/pharmaceutics14081545.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Rational Design of Self-Emulsifying Pellet Formulation of Thymol: Technology Development Guided by Molecular-Level Structure Characterization and Ex Vivo Testing
Authors MACKŮ, Jan (203 Czech Republic, belonging to the institution), Kateřina KUBOVÁ (203 Czech Republic, guarantor, belonging to the institution), Martina URBANOVA, Jan MUSELÍK (203 Czech Republic, belonging to the institution), Aleš FRANC (203 Czech Republic, belonging to the institution), Gabriela KOUTNÁ (203 Czech Republic, belonging to the institution), Miroslava PAVELKOVÁ (203 Czech Republic, belonging to the institution), David VETCHÝ (203 Czech Republic, belonging to the institution), Josef MASEK, Eliska MASKOVA and Jiri BRUS.
Edition Pharmaceutics, Basel, MDPI, 2022, 1999-4923.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.400
RIV identification code RIV/00216224:14160/22:00126642
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/pharmaceutics14081545
UT WoS 000847103700001
Keywords in English thymol; solid-state NMR; self-emulsifying pellet; rational design; structure; ex vivo testing
Tags rivok, ÚFT
Tags International impact, Reviewed
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 20/9/2022 15:53.
Abstract
The growing need for processing natural lipophilic and often volatile substances such as thymol, a promising candidate for topical treatment of intestinal mucosa, led us to the utilization of solid-state nuclear magnetic resonance (ss-NMR) spectroscopy for the rational design of enteric pellets with a thymol self-emulsifying system (SES). The SES (triacylglycerol, Labrasol (R), and propylene glycol) provided a stable o/w emulsion with particle size between 1 and 7 mu m. The ex vivo experiment confirmed the SES mucosal permeation and thymol delivery to enterocytes. Pellets W90 (MCC, Neusilin (R) US2, chitosan) were prepared using distilled water (90 g) by the M1-M3 extrusion/spheronisation methods varying in steps number and/or cumulative time. The pellets (705-740 mu m) showed mostly comparable properties-zero friability, low intraparticular porosity (0-0.71%), and relatively high density (1.43-1.45%). They exhibited similar thymol release for 6 h (burst effect in 15th min ca. 60%), but its content increased (30-39.6 mg /g) with a shorter process time. The M3-W90 fluid-bed coated pellets (Eudragit (R) L) prevented undesirable thymol release in stomach conditions (<10% for 3 h). A detailed, ss-NMR investigation revealed structural differences across samples prepared by M1-M3 methods concerning system stability and internal interactions. The suggested formulation and methodology are promising for other lipophilic volatiles in treating intestinal diseases.
Links
GA22-03187S, research and development projectName: Racionální design částicových polysacharidových systémů pro přívod léčiv s širokým spekterem biologické aktivity k terapii sliznic (Acronym: 22-03187S)
Investor: Czech Science Foundation
MUNI/A/1251/2021, interní kód MUName: Vývoj a in-vivo hodnocení inovativního samoemulgujícího částicového systému s obsahem thymolu pro zlepšení podmínek hospodářského chovu králíků (Acronym: Samoemulgující thymolové pelety pro chov králíků)
Investor: Masaryk University
PrintDisplayed: 28/4/2024 00:58